HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation.
Wang Z, Yan C, Du Q, Huang Y, Li X, Zeng D, Mao R, Gurram RK, Cheng S, Gu W, Zhu L, Fan W, Ma L, Ling Z, Qiu J, Li D, Liu E, Zhang Y, Fang Y, Zhu J, Sun B.
Wang Z, et al. Among authors: gurram rk.
Cell Mol Immunol. 2023 Apr;20(4):404-418. doi: 10.1038/s41423-023-00982-6. Epub 2023 Feb 24.
Cell Mol Immunol. 2023.
PMID: 36823235
Free PMC article.